SYFOVRE
Live / Registered — Registered (as of 09 May 2023)
What this means for you
Registered since 09 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90852938
- Registration number
- 7049997
- Mark type
- Stylized text
- Filed
- 28 Jul 2021
- Published for opposition
- 31 May 2022
- Registered
- 09 May 2023
- Attorney of record
- John V. Hobgood, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders
Owner
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
Prosecution history
- 09 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Mar 2023 — USE AMENDMENT FILED
- 05 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Mar 2023 — TEAS STATEMENT OF USE RECEIVED
- 29 Nov 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Oct 2022 — NEW NOA TO ISSUE
- 26 Jul 2022 — NOTICE OF ALLOWANCE CANCELLED
- 28 Jul 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 May 2022 — PUBLISHED FOR OPPOSITION
- 11 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED